Moving forward - Essential questions for the next 10 years

Headache

Volumn 49, Issue SUPPL. 1, 2009, Pages

  Lipton, Richard B ^a,b   Sheftell, Fred D ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NEW ENGLAND CENTER FOR HEADACHE   (United States)

Author keywords

Future direction; Migraine science; Treatment

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; DESIGNER DRUG; TONABERSAT;

BEHAVIOR; BEHAVIOR THERAPY; DISEASE COURSE; ENVIRONMENTAL FACTOR; EVALUATION; HEREDITY; HUMAN; MIGRAINE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPREADING CORTICAL DEPRESSION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; DRUG DESIGN; HUMANS; MIGRAINE DISORDERS;

EID: 58649092144     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01362.x     Document Type: Review

References (23)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002 346 : 257 270.
2. Silberstein SD, Rosenberg J. Multispecialty consensus on diagnosis and treatment of headache. Neurology. 2000 54 : 1553.
3. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Triptans in acute treatment of migraine: A meta-analysis of 53 trials. Lancet. 2001 358 : 1268 1275.
4. Humphrey PP. The discovery and development of the triptans, a major therapeutic breakthrough. Headache. 2008 48 : 685 687.
5. Lipton RB, Silberstein SD, Saper S, Bigal ME, Goadsby PJ. Why headache treatment fails. Neurology. 2003 60 : 1064 1070.
6. Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population. Headache. 2004 44 : 661 668.
7. Rapoport AM, Tepper SJ, Bigal ME, Sheftell FD. The triptan formulations: How to match patients and products. CNS Drugs. 2003 17 : 431 447.
8. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002 22 : 54 61.
9. Edvinsson L. Neuronal signal substances as biomarkers of migraine. Headache. 2006 46 : 1088 1094.
10. Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004 350 : 1104 1110.
11. Ho TW, Mannix LK, Fan X, et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology. 2008 70 : 1304 1312.
12. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: A randomized trial. JAMA. 2007 297 : 1443 1454.
13. Freitag F, Diamond M, Diamond S, Janssen I, Rodgers A, Skobierenda F. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. Headache. 2008 48 : 368 377.
14. Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of C-fos protein-like immunoreactivity within the trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci. 1993 13 : 1167 1177.
15. Bigal ME, Lipton RB. Conceptualizing migraine progression. Neurology. 2008 71 : 848 855.
16. Lipton RB, Bigal ME. Looking to the future: Research designs for study of headache disease progression. Headache. 2008 48 : 58 66.
17. Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: A PET study. Brain. 2004 127 : 220 230.
18. Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache - long-term safety and efficacy. Cephalalgia. 2007 27 : 153 157.
19. Casale TB, Romero FA, Spierings EL. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2008 121 : 105 109.
20. Rothrock JF, Parada VA, Sims C, Key K, Walters NS, Zweifler RM. The impact of intensive patient education on clinical outcome in a clinic-based migraine population. Headache. 2006 46 : 726 731.
21. Matchar DB, Harpole L, Samsa GP, et al. The headache management trial: A randomized study of coordinated care. Headache. 2008 48 : 1294 1310.
22. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 68 : 343 349.
23. Ifergane G, Wirguin I, Shvartzman P. Triptans - why once? Headache. 2006 46 : 1261 1263.